سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum, hydrochlorothiazidum - compresse rivestite con film - amlodipinum 10 mg ut amlodipini besilas, valsartanum 160 mg, hydrochlorothiazidum 25 mg, cellulosum microcristallinum, hydroxypropylcellulosum, silica colloidalis anhydrica, magnesii stearas, talcum, Überzug: poly(alcohol vinylicus), e 171, talcum, macrogolum 4000, acidi methacrylici copolymerum c, natrii hydrogenocarbonas corresp. natrium 0.005 mg, e 172 (flavum), e 172 (rubrum), pro compresso obducto. - essenziale ipertonia - synthetika

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum - compresse rivestite con film - amlodipinum 5 mg ut amlodipini besilas 6.93 mg, valsartanum 80 mg, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, carboxymethylamylum natricum a corresp. natrium 0.202 mg, calcii hydrogenophosphas, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 2.7 mg, hypromellosum, macrogolum 4000, e 171, e 172 (flavum), pro compresso obducto. - essenziale ipertonia - synthetika

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum - compresse rivestite con film - amlodipinum 5 mg ut amlodipini besilas 6.93 mg, valsartanum 160 mg, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, carboxymethylamylum natricum a corresp. natrium 0.403 mg, calcii hydrogenophosphas, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 5.4 mg, hypromellosum, macrogolum 4000, e 171, e 172 (flavum), pro compresso obducto. - essenziale ipertonia - synthetika

سويسرا - الإيطالية - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - amlodipinum, valsartanum - compresse rivestite con film - amlodipinum 10 mg ut amlodipini besilas 13.86 mg, valsartanum 160 mg, cellulosum microcristallinum, amylum pregelificatum, crospovidonum, carboxymethylamylum natricum a corresp. natrium 0.403 mg, calcii hydrogenophosphas, silica colloidalis anhydrica, magnesii stearas, Überzug: lactosum monohydricum 5.4 mg, hypromellosum, macrogolum 4000, e 171, e 172 (flavum), pro compresso obducto. - essenziale ipertonia - synthetika

الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - ipertensione - agenti che agiscono sul sistema renina-angiotensina - trattamento dell'ipertensione essenziale. imprida è indicato in pazienti la cui pressione arteriosa non è adeguatamente controllata con amlodipina o valsartan in monoterapia.

الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - ipertensione - agenti che agiscono sul sistema renina-angiotensina - trattamento dell'ipertensione essenziale. copalia è indicato in pazienti la cui pressione arteriosa non è adeguatamente controllata con amlodipina o valsartan in monoterapia.

الاتحاد الأوروبي - الإيطالية - EMA (European Medicines Agency)

novartis europharm limited - valsartan, amlodipine (as amlodipine besilate) - ipertensione - agenti che agiscono sul sistema renina-angiotensina - trattamento dell'ipertensione essenziale. exforge è indicato in pazienti la cui pressione arteriosa non è adeguatamente controllata con amlodipina o valsartan in monoterapia.

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

farmaprojects, s.a.u. - valsartan and amlodipine - valsartan and amlodipine

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

mylan s.p.a. - valsartan, amlodipine and hydrochlorothiazide - valsartan, amlodipine and hydrochlorothiazide

إيطاليا - الإيطالية - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - olmesartan medoxomil and amlodipine - olmesartan medoxomil and amlodipine